Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Potential circulating biomarkers of circulating chemokines CCL5, MIP-1β and HA as for early detection of cirrhosis related to chronic HBV (hepatitis B virus) infection.

Hu L, Zhu Y, Zhang J, Chen W, Li Z, Li L, Zhang L, Cao D.

BMC Infect Dis. 2019 Jun 14;19(1):523. doi: 10.1186/s12879-019-4130-0.

2.

Treatment of chronic hepatitis B: case selection and duration of therapy.

Leung N.

J Gastroenterol Hepatol. 2002 Apr;17(4):409-14. Review.

PMID:
11982721
3.

[Noninvasive evaluation of liver fibrosis in chronic hepatitis B patients].

Chen Y, Wang BE, Jia JD, Qian LX, Wang TL, Chen MH, Chen GY, He W, Ding HG, Yin SS, Zhang Y, Dong Z.

Zhonghua Gan Zang Bing Za Zhi. 2003 Jun;11(6):354-7. Chinese.

PMID:
12837216
4.

Altered expression of A20 gene in peripheral blood mononuclear cells is associated with the progression of chronic hepatitis B virus infection.

Fan YC, Zhang YY, Sun YY, Wang N, Xiao XY, Wang K.

Oncotarget. 2016 Oct 18;7(42):68821-68832. doi: 10.18632/oncotarget.11993.

5.

The preS deletion of hepatitis B virus (HBV) is associated with liver fibrosis progression in patients with chronic HBV infection.

Li F, Li X, Yan T, Liu Y, Cheng Y, Xu Z, Shao Q, Liao H, Huang P, Li J, Chen GF, Xu D.

Hepatol Int. 2018 Mar;12(2):107-117. doi: 10.1007/s12072-018-9858-x. Epub 2018 Apr 12.

PMID:
29651701
6.

Serum angiotensin-converting enzyme level as a marker of fibrosis in patients with chronic hepatitis B.

Purnak T, Beyazit Y, Oztas E, Yesil Y, Efe C, Torun S, Celik T, Tenlik I, Kurt M, Ozaslan E.

J Renin Angiotensin Aldosterone Syst. 2012 Jun;13(2):244-9. doi: 10.1177/1470320311434241. Epub 2012 Jan 25.

PMID:
22277254
7.

[Relationship between hepatitis B surface antigen, HBV DNA quantity and liver fibrosis severity].

Gao Y, Zou G, Ye J, Pan G, Rao J, Li F, Wei Y, Li X.

Zhonghua Gan Zang Bing Za Zhi. 2015 Apr;23(4):254-7. doi: 10.3760/cma.j.issn.1007-3418.2015.04.005. Chinese.

PMID:
26133815
8.

Effect of entecavir in the treatment of patients with hepatitis B virus-related compensated and decompensated cirrhosis.

Gai XD, Wu WF.

Exp Ther Med. 2017 Oct;14(4):3908-3914. doi: 10.3892/etm.2017.4963. Epub 2017 Aug 18.

9.

Low Serum Hepatitis B Surface Antigen Level Predicts Compensated Cirrhosis Caused by Chronic Hepatitis B in HBeAg Positive Patients in East China.

Jia W, Qi X, Ji YY, Xun YH, Wang H, Zhang WH, Yang JH, Wang JY, Zhu HX, Mao RC, Zhang JM.

Hepat Mon. 2015 Aug 30;15(8):e29183. doi: 10.5812/hepatmon.29183. eCollection 2015 Aug.

10.

Platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) are associated with chronic hepatitis B virus (HBV) infection.

Zhao Z, Liu J, Wang J, Xie T, Zhang Q, Feng S, Deng H, Zhong B.

Int Immunopharmacol. 2017 Oct;51:1-8. doi: 10.1016/j.intimp.2017.07.007. Epub 2017 Jul 28.

PMID:
28759808
11.

Clinical significance of connective tissue growth factor in hepatitis B virus-induced hepatic fibrosis.

Piao RL, Brigstock DR, Zhu J, Zhang ML, Gao RP.

World J Gastroenterol. 2012 May 14;18(18):2280-6. doi: 10.3748/wjg.v18.i18.2280.

12.

How to estimate renal function in patients with liver disease: choosing the most suitable equation.

Ren S, Chang Y, Zhang Q, Wang X, Niu H, Chen L, Lv C, Zhang Z, Xiang X, Zhu L, Li H.

Int Urol Nephrol. 2019 Apr;51(4):677-690. doi: 10.1007/s11255-019-02110-8. Epub 2019 Mar 4.

PMID:
30830657
13.

Blocking and reversing hepatic fibrosis in patients with chronic hepatitis B treated by traditional Chinese medicine (tablets of biejia ruangan or RGT): study protocol for a randomized controlled trial.

Qu J, Yu Z, Li Q, Chen Y, Xiang D, Tan L, Lei C, Bai W, Li H, Shang Q, Chen L, Hu X, Lu W, Li Z, Chen D, Wang X, Zhang C, Xiao G, Qi X, Chen J, Zhou L, Chen G, Li Y, Zeng Z, Rong G, Dong Z, Chen Y, Lou M, Wang C, Lu Y, Zhang C, Yang Y.

Trials. 2014 Nov 10;15:438. doi: 10.1186/1745-6215-15-438.

14.

Autoantibodies in Chinese patients with chronic hepatitis B: prevalence and clinical associations.

Li BA, Liu J, Hou J, Tang J, Zhang J, Xu J, Song YJ, Liu AX, Zhao J, Guo JX, Chen L, Wang H, Yang LH, Lu J, Mao YL.

World J Gastroenterol. 2015 Jan 7;21(1):283-91. doi: 10.3748/wjg.v21.i1.283.

15.

Serum sphingomyelin has potential to reflect hepatic injury in chronic hepatitis B virus infection.

Zheng SJ, Qu F, Li JF, Zhao J, Zhang JY, Liu M, Ren F, Chen Y, Zhang JL, Duan ZP.

Int J Infect Dis. 2015 Apr;33:149-55. doi: 10.1016/j.ijid.2015.01.020. Epub 2015 Jan 24.

16.

Serum Immunoglobulin A (IgA) Level Is a Potential Biomarker Indicating Cirrhosis during Chronic Hepatitis B Infection.

Lin S, Sun Q, Mao W, Chen Y.

Gastroenterol Res Pract. 2016;2016:2495073. doi: 10.1155/2016/2495073. Epub 2016 Mar 30.

17.

Viral load speaks little about toll on liver.

Mahtab MA, Rahman S, Khan M, Kamal M, Mamun AA, Karim MF.

Hepatobiliary Pancreat Dis Int. 2007 Oct;6(5):483-6.

18.

Serum lipid alterations identified in chronic hepatitis B, hepatitis B virus-associated cirrhosis and carcinoma patients.

Wu T, Zheng X, Yang M, Zhao A, Li M, Chen T, Panee J, Jia W, Ji G.

Sci Rep. 2017 Feb 15;7:42710. doi: 10.1038/srep42710.

19.

[The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].

Pei YZ, Han T, Ma XY, Li Y, Xing J, Song ZL.

Zhonghua Gan Zang Bing Za Zhi. 2011 Oct;19(10):743-6. doi: 10.3760/cma.j.issn.1007-3418.2011.10.006. Chinese.

PMID:
22409845
20.

Supplemental Content

Support Center